A reduced expression of RhoGDI2 is associated with venous system invasion and lymph node metastasis, which may lead to the formation of clinical applications for the evaluation of lymph node metastasis in patients with gastric carcinoma. This evidence concerns the gene ARHGDIB and metastatic malignant neoplasm in the lymph nodes.